KELLY PAUL EDWARD purchased 94.2% of their position (200K shares) of RELMADA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $86.1K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/20/2025ACC: 0001213900-25-046088
Director
Since Oct 2018
+200K
Net shares
Net buyer
$86.1K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
200K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+200K
Price / share
$0.43
Trade value
$86.06K
% of position
94.2%
5/16/2025
212.29K→412.30K
Total
Net shares
+200K
Net value
$86.06K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/16/2025 | P · Purchase | +200K | $0.43 | $86.06K | 94.2% | 212.29K | 412.30K |
| Total | +200K | $86.06K | ||||||
Derivative Transactions0
No derivative transactions reported